| Sachin Gupta, MD | |
|
7130 N Millbrook Ave, Suite 100, Fresno, CA 93720 | |
| (559) 326-1238 | |
| (559) 326-1230 |
| Full Name | Sachin Gupta |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 24 Years |
| Location | 7130 N Millbrook Ave, Fresno, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144343005 | NPI | - | NPPES |
| PO1345515 | Other | CA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A111493 (California) | Primary |
| 207RX0202X | Internal Medicine - Medical Oncology | A111493 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Agnes Medical Center | Fresno, CA | Hospital |
| Clovis Community Medical Center | Clovis, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| California Cancer Associates For Research And Excellence Inc | 8022918937 | 44 |
News Archive
A new survey indicates that among large employers, many have not examined data on physician quality or shared health plan or physician data with employees that could help improve the value and quality of health benefits, according to a study in the November 21 issue of JAMA.
Scientists at The Scripps Research Institute (TSRI) have demonstrated a drug-discovery strategy with a double payoff-it enables the rapid selection of chemical compounds that have a desired effect on cells and also highlights how the compounds work.
BioCurex Inc. today announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healthy individuals were also tested.
A neuroimaging study suggests that patients with schizophrenia have difficulty deactivating the default mode network, rather than having increased absolute metabolic activity.
› Verified 4 days ago
| Entity Name | California Cancer Associates For Research And Excellence Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083661607 PECOS PAC ID: 8022918937 Enrollment ID: O20040108001068 |
News Archive
A new survey indicates that among large employers, many have not examined data on physician quality or shared health plan or physician data with employees that could help improve the value and quality of health benefits, according to a study in the November 21 issue of JAMA.
Scientists at The Scripps Research Institute (TSRI) have demonstrated a drug-discovery strategy with a double payoff-it enables the rapid selection of chemical compounds that have a desired effect on cells and also highlights how the compounds work.
BioCurex Inc. today announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healthy individuals were also tested.
A neuroimaging study suggests that patients with schizophrenia have difficulty deactivating the default mode network, rather than having increased absolute metabolic activity.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sachin Gupta, MD Po Box 25100, Fresno, CA 93729-5100 Ph: (559) 326-1222 | Sachin Gupta, MD 7130 N Millbrook Ave, Suite 100, Fresno, CA 93720 Ph: (559) 326-1238 |
News Archive
A new survey indicates that among large employers, many have not examined data on physician quality or shared health plan or physician data with employees that could help improve the value and quality of health benefits, according to a study in the November 21 issue of JAMA.
Scientists at The Scripps Research Institute (TSRI) have demonstrated a drug-discovery strategy with a double payoff-it enables the rapid selection of chemical compounds that have a desired effect on cells and also highlights how the compounds work.
BioCurex Inc. today announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healthy individuals were also tested.
A neuroimaging study suggests that patients with schizophrenia have difficulty deactivating the default mode network, rather than having increased absolute metabolic activity.
› Verified 4 days ago
Maulik Shah, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7300 N Fresno St, Fresno, CA 93720 Phone: 559-448-4555 | |
Rami Alrezk, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 155 N Fresno St, Fresno, CA 93701 Phone: 559-499-6479 | |
Dr. John R Nelson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7061 N Whitney, Suite 101, Fresno, CA 93720 Phone: 559-299-0224 Fax: 559-299-4201 | |
Dexter T Estrada, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7130 N Millbrook Ave Ste 100, Fresno, CA 93720 Phone: 559-326-1222 Fax: 559-326-1230 | |
Dr. Sherry Lopez, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3209 W Shaw Ave, Suite 114, Fresno, CA 93711 Phone: 559-224-4977 Fax: 559-224-4980 | |
Maria Flordeliz Arambulo, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6484 Fax: 559-499-6501 | |
Shreela Mishra, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7085 N Chestnut Ave Ste 101, Fresno, CA 93720 Phone: 559-323-9236 Fax: 559-323-0294 |